Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Envoy Medical (COCH) Operating Income (2022 - 2025)

Historic Operating Income for Envoy Medical (COCH) over the last 4 years, with Q3 2025 value amounting to -$5.7 million.

  • Envoy Medical's Operating Income fell 1480.29% to -$5.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$20.4 million, marking a year-over-year increase of 465.21%. This contributed to the annual value of -$19.3 million for FY2024, which is 488.59% down from last year.
  • Latest data reveals that Envoy Medical reported Operating Income of -$5.7 million as of Q3 2025, which was down 1480.29% from -$5.1 million recorded in Q2 2025.
  • In the past 5 years, Envoy Medical's Operating Income ranged from a high of -$901356.0 in Q2 2022 and a low of -$6.7 million during Q4 2023
  • In the last 4 years, Envoy Medical's Operating Income had a median value of -$4.5 million in 2024 and averaged -$4.0 million.
  • Its Operating Income has fluctuated over the past 5 years, first crashed by 39702.89% in 2023, then soared by 3233.68% in 2024.
  • Over the past 4 years, Envoy Medical's Operating Income (Quarter) stood at -$2.9 million in 2022, then plummeted by 131.35% to -$6.7 million in 2023, then soared by 32.34% to -$4.5 million in 2024, then dropped by 25.48% to -$5.7 million in 2025.
  • Its last three reported values are -$5.7 million in Q3 2025, -$5.1 million for Q2 2025, and -$5.1 million during Q1 2025.